knowledge -WSS

knowledge

author：knowledge 2025-10-01 05:39:08 - browse：831

The Amgen booth at ESMO in Madrid. Andrew Joseph/STAT

MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug.

The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also published Friday in the New England Journal of Medicine.

“It’s a single arm study, but the results are amazing,” said Silke Gillessen, the scientific chair of ESMO 2023 and an oncologist at the Oncology Institute of Southern Switzerland, noting that advances in small cell lung cancer have been slow to come.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： HCA discloses massive data breach affecting 11 million patients

entertainment

WSS

Why 40% Americans with Parkinson’s don’t see a neurologist

Megan Rapinoe shares emotional post following US Women's World Cup exit

YouTube cracks down on misinformation on cancer treatment

Oak trusses raised to roof of fire

Mark Cuban is blaming the wrong people for high drug costs

Hospitals are dialing back on venture capital investing

focus

knowledge

leisure time

Psychedelics group wrestles with new pharma identity

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Psychedelics group wrestles with new pharma identity

Maui wildfire now ranks as the fifth

Dobbs anniversary: the lost opportunity of abortion as health care

Senators push IRS to launch nonprofit hospital probe

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Leqembi, other new Alzheimer’s drugs require better biomarkers

Anesthesiologist group: stop taking Ozempic before surgery

California’s proposed $25 per hour health care minimum wage

Wikipedia

Timeline: How the deadly wildfires took over Maui day by day

Dozens dead from Maui wildfires: What we know about the victims

Aspartame and sugar

What to know about OceanGate, the company behind the missing Titanic submersible

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

A new study sees potential in DNA sequencing of infants

focus

focus

entertainment

entertainment